Divalent cations, including Zinc and Manganese ions, are important modulators of cell activation. We investigated the ability of these two divalent cations to modulate apoptosis in human Burkitt lymphoma B cells line (Ramos). We found that Zinc (from 10 to 50 mM) inhibited Manganese-induced caspase-3 activation and apoptosis of Ramos cells. Higher concentration of Zinc (50 to 100 mM) did not prevent Manganese-mediated apoptosis but rather increased cell death among Ramos cells. This Zinc-mediated cell death was associated with apoptotic features such as cell shrinkage, the presence of phosphatidylserine residues on the outer leaflet of the cells, chromatin condensation, DNA fragmentation and decrease of mitochondrial transmembrane potential. Zincmediated apoptosis was associated with caspase-9 and caspase-3 activation as revealed by the appearance of active p35 fragment of caspase-9 and p19 and p17 of caspase-3 as well as in vivo cleavage of PARP and of a cell-permeable fluorogenic caspase-3 substrate (Phiphilux-G 1 D 2 ). Both Zincmediated apoptosis and caspase-3 activation were prevented by the cell-permeable, broad-spectrum inhibitor of caspases (zVAD-fmk) or overexpression of bcl-2. In addition, we show that Zinc-induced loss of transmembrane mitochondrial potential is a caspase-independent event, since it is not modified by the presence of zVAD-fmk, which is inhibited by overexpression of bcl-2. These results indicate that depending on its concentration, Zinc can exert opposite effects on caspase-3 activation and apoptosis in human B lymphoma cells: concentrations below 50 mM inhibit caspase-3 activation and apoptosis whereas higher concentrations of Zinc activate a death pathway associated with apoptotic-like features and caspase-3 activation. Cell Death and Differentiation (2001) 8, 152 ± 161.
Introduction
Various cellular functions are influenced by essential traceelements such as the divalent cations Zinc (Zn 2+ ) and Manganese (Mn 2+ ). The physiological concentrations of these cations are strictly controlled and divergence from normal levels are associated with various diseases. 1 ± 6 For instance, Zn 2+ deficiency is mostly associated with increased apoptosis resulting in thymus atrophy, loss of splenocytes and lymphopenia, suggesting that this deficiency alters the apoptotic process involved in normal lymphopoiesis. 7 ± 9 Nevertheless, Zn 2+ -mediated regulation of apoptosis in vivo is probably more complex. Thus, patients with Down's Syndrome, have low plasma Zn 2+ levels and present both immature myeloid cells in peripheral blood and large numbers of apoptotic peripheral blood cells. 6, 10 Several studies have shown that Zn 2+ supplementation in Down's Syndrome patients results both in the disappearance of peripheral myeloid precursor cells through an apoptotic process and the reduction of apoptotic peripheral blood cells. 6, 10 These studies demonstrated that, in vivo, Zn 2+ can exert opposite effects on apoptosis, although the molecular basis of these different activities have not yet been elucidated. Pharmacological Zn 2+ supplementation is not only able to restore an impaired immune response but also improve normal immune function by raising the physiological Zn 2+ serum level of 8 ± 12 mM about 10-fold to 100 mM. 11 Higher concentrations of extracellular Zn 2+ (500 ± 1000 mM) have frequently been used to block apoptosis in a variety of systems. Surprisingly, lower and more physiological concentrations of Zn 2+ (80 ± 200 mM) can induce partial death in thymocytes. 12 Numerous metalloenzymes are Zn 2+ -dependent and require Zn 2+ for their structure, catalytic activity or regulation. 9,10,13 ± 16 Zn 2+ also regulates the activity of metalloproteins dependent on other cations. For example, Zn 2+ inhibits the activity of a Ca 2+ /Mg 2+ -dependent endonuclease involved in internucleosomal DNA fragmentation observed during apoptosis. 17 The average content of intracellular labile Zn 2+ , as measured by zinquin (a membrane-permeant fluorophore specific for Zn 2+ ) was approximately 20 pmol/10 6 cells in leukemic lymphocytes. 18 When intracellular pool was increased under conditions that suppress apoptosis, most of the labile Zn 2+ appeared to be localized in the cytoplasm within membrane-enclosed vesicles. This may indicate that target molecules are primarily cytoplasmic as caspases. 19 Zn 2+ directly inhibits the activity in vitro of various recombinant caspases including caspase-3, -6, -7 and -8. 20, 21 These caspases are cysteine-related proteases, which are synthesized as inactive proenzymes and activated in vivo during most apoptotic processes. The proenzymes are activated by cleavage at particular aspartate sites: the cleavage products form dimers which are the active forms. 22 Some caspases, such as caspase-9, may activate other family members, and final activation may also result from autoprocessing as reported for caspase-3. 23, 24 Caspase activation in a cell is followed by cleavage of numerous substrates and changes in the plasma membrane, mitochondria and the nucleus. More than 10 different caspases have been described and several reports indicate that caspase-3 is a major effector of nuclear apoptotic events. 25 ± 29 We previously reported that Mn 2+ , another divalent cation, can trigger apoptosis in human B cells and this apoptosis is associated with caspase-3 activation. 30 Therefore, to precise the role of divalent cations in the control of apoptosis, we evaluated the ability of Zn 2+ to modulate both apoptosis and caspase-3 activation induced by Mn 2+ . We found that Zn 2+ exerts opposite effects on caspase-3 activation and apoptosis of Ramos human B lymphoma. At concentrations up to 50 mM, Zn 2+ inhibits the loss of mitochondrial membrane potential (DCm), and the activation of both caspase-9 and caspase-3 associated with apoptosis induced by Mn 2+ . In contrast, no such inhibition of Mn 2+ -mediated apoptosis was observed with higher concentrations of Zn 2+ . Moreover, when used at concentrations of 60 ± 100 mM, Zn 2+ activated a death pathway associated with caspase-9 and caspase-3 activation and apoptotic-like features which was inhibited in the presence of the caspase inhibitor zVAD-fmk or by overexpression of the Bcl-2 protein.
Results
Dual effect of Zn 2+ on Mn 2+ -mediated apoptosis
We previously reported that human Burkitt lymphoma B cell lines, such as Ramos cells, were sensitive to Mn 2+ -mediated apoptosis and that this apoptosis was associated with caspase-3 activation. 30 Several groups have reported that Zn 2+ inhibits caspase-3 activity and apoptosis. 20, 21, 31 We first studied the effect of various doses of Zn 2+ on Mn 2+ -induced death of Ramos cells. Apoptosis was followed by measuring cell shrinkage or chromatin condensation evidenced by the appearance of hypodiploid nuclei. Zn 2+ at doses from 20 to 50 mM significantly decreased the apoptosis of Ramos cells observed in the presence of 80 mM Mn 2+ ( Figure 1A) . We next investigated which steps of the Mn 2+ -induced apoptotic cascade were sensitive to the protective doses of Zn 2+ . For this, we first tested the ability of Zn 2+ (40 mM) to interfere with the loss of mitochondrial membrane potential (DCm) induced by apoptotic concentrations of Mn 2+ (80 mM). There was a significant inhibition (52%) of the Mn 2+ -mediated loss of DCm as quantified by staining with DiOC 6 (3) ( Figure 1B ). Thus, this protective effect of Zn 2+ is manifest at an early stage, at the mitochondrial level. The mechanism of this effect remains to be more precisely characterized. We then verified whether activation of downstream caspases such as caspase 9 and 3 were also inhibited by 40 mM Zn 2+ ( Figure 2 ). The protective effect of Zn 2+ was associated with inhibition of Mn 2+ -induced activation of caspase-9 (assessed as the production of active cleaved 37 fragment of caspase-9: Figure 2A ) and caspase-3 (assessed as the production of active cleaved p19 and p17 fragments of caspase-3 or cleavage of the caspase-3 substrate PARP from the 110 kDa form to the 83 kDa fragment) in intact cells ( Figure 2B Zinc-mediated cell death is associated with apoptotic phenomena
We next analyzed the features of Zn
2+
-treated Ramos cells and in particular studied cytoplasmic and nuclear events ( Figure 3) . Zn 2+ at a final concentration of 60 mM induced cell shrinkage (52% vs 9% in control cells after 24 h of stimulation) as assessed by cell dot-blot light scatter profiles and flow cytometry ( Figure 3A) . Cell shrinkage correlated with cell viability, tested by trypan blue exclusion (data not shown). This cell shrinkage was also correlated with the presence of phosphatidylserine residues detected by Annexin V in these cells (57% vs 11.7% in control after 24 h of stimulation) ( Figure 3B ). Importantly, we consistently observed that, in Figure 2 Zn 2+ -mediated inhibition of Mn 2+ -induced apoptosis is associated with inhibition of caspase-9 and caspase-3 processing and activity. Ramos were cultured for 48 h in the absence (7) or in the presence of Mn 2+ (80 mM) and various concentrations of Zn 2+ . (A) The amounts of p37 active subunit of caspase-9 and (B) p32 proform and p19 and p17 subunits of caspase-3 were analyzed by Western blotting with specific anti-cleaved caspase-9 and anticaspase-3 antibodies respectively. (B) PARP cleavage was analyzed by Western blotting with an anti-PARP antibody (7) 7 ) observed with Zn 2+ (60 mM) was maximum at 24 h whereas most of the dead cells observed at 48 h were necrotic (data not shown). Zn 2+ -mediated cell death was also associated with chromatin condensation evidenced by the presence, after PI staining, of hypodiploid nuclei (17.7% vs 6.2% in control non activated cells) ( Figure  3C ). Moreover, DNA extracted from 24 h Zn 2+ -activated cells exhibited also orderly fragmentation resulting in the appearance of a ladder-like cleavage pattern after electrophoresis ( Figure 3D ). This DNA fragmentation was similar to that observed in cells treated with 80 mM Mn 2+ , whereas DNA extracted from cells treated with 100 mM Mg 2+ , which did not exhibit cell mortality features, was similar to DNA from control cells. These results showed that 60 mM Zn 2+ induced substantial cell death of Ramos cells, and that this cell death, at least in an important fraction of these cells, was associated with phosphatidylserine expression on the outer leaflet of the cells without loss of cell membrane integrity, chromatin condensation and DNA fragmentation, all typical of apoptotis. Nevertheless, we did not observe nuclear fragmentation in Zn 2+ -treated Ramos cells whereas similar activation with Mn 2+ promoted substantial fragmentation of Ramos cell nuclei (data not shown and 30 ).
Zn

2+ -induced caspase-3 activation in Ramos cells is inhibited by the caspase inhibitor zVAD-fmk
We therefore investigated whether high doses of Zn 2+ (60 mM) stimulated caspase-3 activation. We used Western blotting to follow the appearance of cleaved active fragments of caspase-3 and quantified caspase-3 activation by monitoring the cleavage in vivo of both the natural substrate PARP and a synthetic substrate containing the caspase 3 target sequence GDEVDG (Phiphilux G 1 D 2 ) (Figure 4 ). Sixty mM Zn 2+ induced the processing of caspase-3 proform into the active fragments p19 and p17. This caspase-3 activation was assayed by following the cleavage in vivo of PARP from the 110 kDa form to the 83 kDa fragment ( Figure 4A ). Proteolytic processing of caspase-3 and of the caspase-3 substrate PARP can occur during cell lysis through release of activated proteases, like granzyme B in T lymphocytes, able to cleave and activate caspase-3 in vitro. 32 We verified that Zn 2+ could also activate caspase-3 in intact cells using a cell-permeable fluorogenic caspase-3 substrate containing the sequence GDEVDG ( Figure 4B ). We next investigated whether inhibition of caspase activity with a broad spectrum inhibitor of caspase (zVAD-fmk) influenced Zn 2+ -induced caspase-3 activation in Ramos cells. One hundred mM zVAD-fmk completely inhibited the appearance of the active cleaved fragments of caspase-3 and cleavage of PARP ( Figure 4A + vs 22% in the presence of zVAD and 7% in control cells respectively) was not significantly modified ( Figure 4A ). These results demonstrate that inhibition of caspase activity by zVAD-fmk abolished Zn 2+ -mediated caspase-3 activation and the apoptotic features associated with cell death, indicating that Zn 2+ can promote caspase-3 activation in a caspase-dependent manner. We therefore investigated the ability of Zn to activate other caspases, 
2+ (60 mM) induced the processing of the caspase-9 proform into the active fragment p37 ( Figure 5 ).
Overexpression of bcl-2 is sufficient to inhibit Zn 2+ -induced caspase-3 activation
The bcl-2 protein is a potent inhibitor of both apoptosis and caspase-3 activation in diverse cells. Overexpression of bcl-2 counteracts apoptosis of human lymphoma B cells induced by Mn 2+ . 30 We therefore studied whether overexpression of bcl-2 protein in Ramos cells modified the sensitivity of these cells to Zn 2+ -induced caspase-3 activation and cell death. We first isolated a subclone of Ramos cells transfected with the human bcl-2 gene (Ramos-bcl-2) and checked that the clone overproduced the protein bcl-2. 30 Ramos and Ramos-bcl-2 cells were activated with 100 mM Zn 2+ and caspase-3 activation and cell shrinkage were analyzed ( Figure 6 ). Overexpression of bcl-2 prevented Zn 2+ -mediated caspase-3 activation as indicated by the lack of production of p19 and p17 fragments and in vivo cleavage of PARP in Ramos-bcl2 cells as compared to Ramos. Caspase-3 activation was not observed in the presence of higher concentrations of Zn 2+ (data not shown). In parallel experiments, we studied the effect of bcl-2 overexpression on nuclear (chromatin condensation) and cell morphology (PS -activated Ramos and Ramos-bcl-2 respectively) were prevented by overexpression of bcl-2 ( Figure 6B ). Thus, overexpression of bcl-2 can prevent Zn 2+ -mediated caspase-3 activation and apoptosis.
Zn
2+ -induced mitochondrial transmembrane potential (DCm) loss is caspase-independent
To precise the cascade of events promoted by Zn 2+ and leading to caspase-3 activation, we next measured, by staining with DiOC 6 (3) and HE, the loss of mitochondrial membrane potential (DCm) which is an early and irreversible step in apoptotic process and the generation of superoxide anions respectively. 33 Zn 2+ at 60 mM significantly increases the percentage of cells with low DCm (39% vs 22% in control, cells) ( Figure 7A ) and ethydium positive cells (38% vs 19% in control cells) ( Figure 7B ). When Zn 2+ -mediated cell shrinkage was inhibited with different concentrations of zVAD-fmk, only superoxide anions production was reduced whereas the percentage of cells exhibiting a low DCm remains similar to that observed in cells activated with Zn 2+ in the absence of zVAD-fmk ( Figure 7C ). These data indicate that Zn 2+ can promote mitochondrial modification associated to apoptosis, such as loss of DCm, in a caspase-independent manner. In addition, we show that this loss of mitochondrial membrane potential is regulated by bcl-2, since overexpression of bcl-2 strongly inhibited loss of DCm observed with 100 mM Zn 2+ ( Figure 7D ) whereas DCm decrease obtained with 60 mM Zn 2+ was completely abrogated (data not shown).
Discussion
In this report, we show that the ability of Zn 2+ to modulate apoptosis in the human Burkitt cell line Ramos is a complex : the percentages of PS + /PI 7 and PS + /PI + cells and hypodiploid nuclei were enumerated as previously described Figure 5 Zn 2+ -mediated-caspase-9 processing. Ramos cells were cultured in the absence (7) or the presence of 60 mM Zn 2+ (+) for 8 h. The amount of active cleaved caspase-9 (p37) was determined by Western blotting using a specific anti-p37 caspase-9 Ab. The amount of protein loaded in each lane was assessed by re hybridization of the filter with an Ab specific for human actin
Cell Death and Differentiation
Zinc-mediated caspase-3 activation N Schrantz et al process which depends on the dose. We observed that concentrations of Zn 2+ above 50 mM activated caspase-3 in intact cells. This activation was evidenced by in vivo cleavage of the caspase-3 substrate PARP. To rule out a possible postlytic, non-specific activation of caspase-3 in vitro as reported for PHA-activated T cells, 32 we verified that Zn 2+ could directly promote the cleavage in intact cells of a cell permeable fluorogenic caspase-3-like substrate containing the sequence GDEVDG (Phiphilux G 1 D 2 ). These experiments showed that 60 mM Zn 2+ induced in vivo activation of caspases and cleavage of PARP and the sequence GDEVDG. The direct involvement of caspase-3 activation during this process was evidenced by the production in Zn 2+ -activated Ramos cells of cleaved forms p19 and p17 recognized with a specificcaspase-3 antibody. In untreated control cells only the p32 proform of caspase-3 was detected. Although we can not exclude that other caspases able to cleave PARP or the sequence DEVD, such as caspase-2 or 7, could also be responsible for the caspase activity detected in Zn 2+ -activated cells, our data provide for the first time evidence that Zn 2+ promotes a process leading to activation of caspase-3 in intact Burkitt cells.
It has recently been proposed that the caspase-3 proform can be cleaved into active forms by caspase-9 activated by a molecular complex including Apaf1 and cytochrome c. 34 In our experimental conditions, the large caspase inhibitor zVAD-fmk not only prevented cleavage of caspase-3 substrates but also prevented the appearance of the cleaved fragments p19 and p17 of caspase-3. Thus, Zn 2+ -mediated caspase-3 activation appears to be dependent on the activation of upstream regulatory caspases. Indeed, caspase-9, which is the caspase responsible for direct cleavage and therefore activation of caspase-3, is also activated in the presence of apoptotic doses of Zn 2+ . Implication of upstream mitochondrial events during Zn 2+ -induced caspase-3 activation is emphasized by the observation that this activation is (i) associated with loss of mitochondrial membrane potential and (ii) prevented by overexpression of the protooncogene bcl-2, which is thought to be a major regulator of the mitochondrial permeability transition pores governing the release of apoptotis regulators such as cytochrome c, AIF and caspase-9 itself.
± 36
Furthermore, we show that zVAD-fmk does not prevent Zn 2+ -mediated loss of DCm showing that the mitochondrial membrane potential dissipation induced by Zn 2+ is not a consequence of a direct effect of caspase activity. These data strongly suggest that the pathway leading to caspase-3 activation by Zn 2+ involves both caspase-dependent and -independent steps (Figure 8 ). In addition, this apoptotic pathway does not require protein synthesis since apoptosis triggered by Zn 2+ was not inhibited in the presence of cycloheximide (data not shown).
Interestingly, lower doses of Zn 2+ (below 50 mM) did not activate caspase-3 but on the contrary inhibited both apoptosis and caspase-3 activation promoted in Burkitt B cells by the divalent cation Mn 2+ . These observations fit well with the Zn 2+ -mediated inhibition of various caspases, including caspase-3 and caspase-6, previously reported by other groups. 21, 22, 31 In our experimental conditions, Zn 2+ -mediated inhibition of Mn 2+ -induced caspase-3 activation was associated with decrease in the amounts of both p19 and p17, the active fragments of caspase-3. As cleavage of the p19 form to the 17 kDa fragment is dependent on the autocatalytic activity of caspase-3, 23, 37 it is possible that Zn 2+ -mediated inhibition of PARP cleavage is associated with a decrease in the production of the active p19 fragment. This downregulation of active caspase-3 fragments expression by Figure 7 Effect of ZVAD-fmk on Zn 2+ -mediated mitochondrial transmembrane potential dissipation and superoxide anions production. Ramos cells were cultured in the absence or in the presence of 60 mM Zn 2+ for 8 h and then stained for DiOC 6 (3) (A) and HE (B) for analysis of mitochondrial transmembrane potential dissipation and superoxide anions production respectively. (C) Cells were cultured without or with 60 mM Zn 2+ and various concentrations of ZVAD-fmk for 8 h and analyzed for cell shrinkage, loss of mitochondrial transmembrane potential and production of superoxyde anions. The number of each cell population was enumerated as a percentage of the total population. Ramos and Ramos-bcl-2 cells were cultured without (broken line) or with (continuous line) 100 mM Zn 2+ for 12 h and then stained for DiOC 6 (3) for analysis of mitochondrial transmembrane potential dissipation
Zn
2+ could be achieved in two different ways: Zn 2+ may inhibit some upstream events leading to Mn 2+ -mediated caspase-3 activation and/or may upregulate the degradation of active caspase-3 fragments. Indeed, we observed that Zn 2+ could interfere with upstream events: it both prevented the loss of the mitochondrial membrane potential (DCm) and inhibited caspase-9 activation induced by apoptotic concentrations of Mn 2+ . Two different groups recently reported that Zn 2+ can directly inhibit the protease activity of recombinant caspase-3 in vitro. Perry et al. reported Zn 2+ -mediated inhibition with an IC 50 of 0.1 mM whereas Stennicke et al. observed a complete inhibition of caspase-3 with 1 mM of Zn 2+ .
20,21
Although it is difficult to compare concentrations of Zn 2+ available in cells for caspase-3 in our experimental conditions of those described for in vitro assays with recombinant caspases, we also observed a similar activity in the presence of high concentrations of Zn 2+ (from 100 mM). Indeed, Zn 2+ -mediated caspase-3 activation is associated with the expression of both p19 and p17, the active fragments of caspase-3. However, in contrast to what was observed with Mn 2+ , there was always more p19 than p17 in Zn 2+ -activated Ramos cells (Figure 2 vs 4) . Since p17 is the autocleavage product of p19, this accumulation of p19 is probably the result of a partial inhibition of the caspase-3 activity by Zn 2+ . Thus, increased Zn 2+ concentrations should also increase inactivation of caspase-3 activity and lead to the only expression of the p19 form. Unfortunately, in our experimental conditions, concentrations of Zn 2+ superior to 100 mM, which should be associated to p19 expression, trigger rapid necrotic death of most cells associated with non specific proteolysis of caspase-3 proform and cleaved fragments (data not shown). Our data suggest that activation of caspase-3 observed in intact cells with Zn 2+ concentrations from 50 to 100 mM results probably from a balance between activation of a pathway, including loss of the mitochondrial membrane potential (DCm) and caspase-9 activation leading to cleavage and activation of procaspase-3 and a direct inhibition of caspase-3 activity.
Activation of caspase-3 by Zn 2+ is associated with apoptosis of Ramos cells. This apoptosis presents typical features including cellular events (cell shrinkage and expression of phosphatidylserine residues on the outer leaflet of the cell membrane) and nuclear events (chromatin condensation, DNA cleavage and nuclear fragmentation). This apoptotic process is prevented in the presence of the broad-spectrum caspase inhibitor zVAD-fmk. Such apoptosis is always associated with necrosis which becomes the major cell death process when Zn 2+ is present at concentrations above 100 mM and after 48 h of Zn 2+ -activation (data not shown). This raises the question of the interaction between Zn 2+ -mediated apoptotic and necrotic-like death. Vercammen et al. recently reported that Fas can activate different pathways leading to apoptosis or necrosis. 38, 39 They show that caspase inhibitors block Fas-mediated apoptosis and promote the triggering of a necrotic pathway that involves oxygen radical production. However the dual apoptotic/necrotic death induced by Zn 2+ seems different from Fas-induced cell death for various reasons: (i) in our conditions, the presence of zVAD-fmk which blocks apoptosis did not affect necrotic cell death within the first 24 h. In contrast, after 48 and 72 h almost all the cells became necrotic and this necrosis was not modified by z-VAD; (ii) we are not able to prevent Ramos cell death in the presence of radical scavengers (data not shown) although superoxide production was associated with an Zn 2+ -activation in as yet poorly characterized caspase-dependent pathway. Thus, Zn 2+ -induced necrotic cells do not result from apoptotic cells because (i) prevention of Ramos cells apoptosis by zVADfmk did not prevent the emergence of necrotic cells (in the same way, overexpression of bcl-2 which strongly inhibits apoptosis and also reduced necrosis observed at 24 h does not prevent the massive necrosis observed between 48 and 72 h of activation with Zn 2+ ) and (ii) Zn 2+ can directly trigger caspase-independent necrosis in other B cell types, including other Burkitt cell lines without detectable apoptosis (data not shown).
In conclusion, our data provide the first evidence that Zn 2+ may regulate caspase-3 activation and apoptosis in Ramos Burkitt lymphoma cells in a dual fashion. Caspase-3 is either inhibited or activated by Zn 2+ depending on the concentration of cation used and these opposite effects are observed in a narrow range (20 ± 100 mM) of Zn 
BL cell lines and bioassays
The Burkitt lymphoma cell line Ramos was obtained from ATCC (Rockville, MD, USA). Ramos cells were negative for the presence of the EBV genome and were cultured in RPMI 1640 Glutamax culture medium (Seromed, Biochrom, Berlin, Germany) supplemented with 100 U/ml penicillin, 100 mM streptomycin and 5% fetal bovine serum (Gibco, Grand Island, NY, USA) in 24-well flat-bottomed microtest plates (Falcon, Oxnard, CA, USA).
Cell transfection
The pSFFV-bcl2-neo vector which carries the human bcl-2 cDNA was used to transfect Ramos cells by electroporation. Stable transfectants were isolated and overproduction of Bcl-2 protein by Ramos-bcl-2 cells was verified by flow cytometry using a FITClabeled anti-human Bcl-2 monoclonal antibody (DAKO A/S, Denmark).
Determination of cell death and apoptosis.
Analysis of dot-blot light scatter profiles Cells (10 6 ) were washed in PBS and resuspended in PBS containing paraformaldehyde (1%). Cells were analyzed for their dot-blot light scatter profiles by flow cytometry using a FACScan flow cytometer (Becton-Dickinson, Mountain View, CA, USA). Apoptotic cells which have a relatively high side-scatter and low forward-scatter properties were enumerated as a percentage of the total population.
Analysis of mitochondrial transmembrane potential and superoxide anions production DCm was evaluated by staining cells (10 6 ) with 40 nM of DiOC 6 (3) (stock solution 1 mM in Ethanol) for 15 min at 378C. For the analysis of superoxide generation, cells (10 6 ) were stained with 1 mM HE (stock solution 500 mM) for 15 min at 378C. The fluorescence emitted by cells was analyzed with a FACScan flow cytometer (Becton-Dickinson) using the FL1 channel for DiOC 6 (3) and FL2 for HE.
Hypodiploid DNA Cells (10 6 ) were washed in PBS and resuspended in 1 ml hypotonic fluorochrome solution (50 mg ml 71 propidium iodide in 0.1% sodium citrate plus 0.1% Triton X-100) (Sigma) as previously described. 42 Samples were placed at room temperature for 1 h before flow-cytometry analysis of PI fluorescence of individual nuclei using a FACScan flow cytometer (BectonDickinson). Debris was excluded from analysis by raising the forward scatter threshold. The DNA content of the intact nuclei was registered on a logarithmic scale. Apoptotic cells were identified as the nuclei having hypodiploid DNA emitting fluorescence in channels 10 ± 200 and were enumerated as a percentage of the total population.
Phosphatidylserine residues expression and loss of cell membrane integrity Cells (10 6 ) were washed in PBS and resuspended in incubation buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) with Annexin-V-FITC (Boehringer Mannheim) and 20 mg/ml propidium iodide (Sigma). After 15 min of incubation at 48C, the fluorescence emitted by cells was analyzed with a FACScan flow cytometer. Cells with phosphatidylserine residues on the outer leaflet and without loss of cell integrity (PS + /PI 7 ) were considered as apoptotic cells whereas PS + /PI + were considered as necrotic cells and PS 7 /PI 7 as viable cells.
Nuclear fragmentation Cells were collected, washed with PBS and fixed for 10 min in PBS containing 4% paraformaldehyde. After centrifugation, cells were resuspended in PBS containing 1 mg/ml DAPI. Nuclear morphology was then monitored under a fluorescence microscope (Leica DM RB).
DNA fragmentation Cells (2610 6 ) were incubated with cations for various periods of time, washed twice in PBS and then lysed with 30 ml of a buffer containing 10 mM Tris (pH 7.5), 5 mM EDTA, and 0.5% Triton X-100 for 30 min at room temperature. Cell lysates were centrifuged at 15 0006g for 20 min and the supernatants incubated with proteinase K (0.2 mg/ml) and ribonuclease A (0.1 mg/ml) at 428C for 1 h. The samples were electrophoresed in a 2% agarose gel in 0.56TBE running buffer (4.5 mM Tris, 4.5 mM boric acid, 62.5 mM EDTA) containing ethidium bromide (10 mg/ml).
Western blotting analysis
Cells were lysed by incubation with modified Laemmli buffer (60 mM Tris, pH 6.8, 10% glycerol, and 2% SDS, without b-mercaptoethanol and bromophenol blue) and sonication for 30 s on ice. The samples were centrifuged for 5 min at 15 0006g. The supernatants were boiled for 5 min and frozen at 7808C or used immediately. Aliquots of the supernatant were assayed for protein concentration (micro-BCA protein assay, Pierce Chemical Co., Rockford, IL, USA). Cell lysate proteins (20 mg per lane) were resolved by 7.5% and 15% SDSpolyacrylamide gel electrophoresis. Proteins were then electroblotted onto 0.45 mm pore-size nitrocellulose filters, and the filters were blocked for 1 h with 5% non-fat milk in PBS, 0.1% Tween-20. The filters were then incubated for 1 h at room temperature with anticaspase-3 Ab (1 mg ml 71 ) (polyclonal rabbit Anti-Caspase-3 antiserum, Pharmingen, San Diego, CA, USA), anti p37 active cleaved caspase-9 Ab (2 mg ml 71 ) (polyclonal rabbit Anti-Caspase-9 antiserum, New England Biolabs Inc, Beverly, MA, USA) or PARP mAb C2.10 (1 mg ml 71 ) (purchased from Dr Poirier, Quebec, Canada). Blots were washed three times for 10 min with 0.2% Tween 20 in PBS and incubated for 1 h with peroxidase-labeled anti-mouse or antirabbit immunoglobulins (1/5000). Blots were developed using an enhanced chemiluminescence detection system (ECL, Amersham Corp., UK).
Detection of active caspase-3 in intact cells
A cell-permeable fluorogenic substrate (Phiphilux-G 1 D 2 ) was used to monitor caspase-3 activity in intact cells, according to the manufacturer's recommendations (OncoImmunin, Inc, Kensington, MD,USA). Briefly, after Zn 2+ stimulation for 8 h, 10 6 cells were collected and resuspended in 50 ml of substrate solution and supplemented with 2.5 ml of fetal calf serum. Cells were incubated in a 5% CO 2 incubator at 378C for 1 h. After incubation, cells were washed once and the fluorescence emission was determined using the FL-1 channel of a FACScan flow cytometer (Becton-Dickinson).
